Literature DB >> 6628889

Quantitative structure-activity relationships and possible mechanisms of action of bispyridinium oximes as antidotes against pinacolyl methylphosphonofluoridate.

C T Su, C P Tang, C Ma, Y S Shih, C Y Liu, M T Wu.   

Abstract

The antidotal efficacy of bispyridinium oximes against the poisoning by pinacolyl methylphosphonofluoridate can be correlated well with their physicochemical parameters. Good correlation was observed between the efficacy of antagonism against pinacolyl methylphosphonofluoridate and antinicotinic action of these oximes. X-ray structural analysis showed that these oximes possessed structural similarity to nicotine and acetylcholine of nicotinic conformation. A new model of antidotal action, other than reactivation, against the poisoning by pinacolyl methylphosphonofluoridate was proposed for these bispyridinium oximes through nicotinic receptor binding. The antagonistic efficacy of these antidotes against pinacolyl methylphosphonofluoridate may be attributed to their direct antagonism at nicotinic receptor as well as reactivation of inhibited acetylcholinesterase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628889     DOI: 10.1016/s0272-0590(83)80139-0

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  3 in total

1.  HI-6 therapy of soman and tabun poisoning in primates and rodents.

Authors:  M G Hamilton; P M Lundy
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro.

Authors:  J E Tattersall
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.

Authors:  H P van Helden; H J van der Wiel; J J Zijlstra; B P Melchers; R W Busker
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.